BioXcel Therapeutics Inc

Analyst Snapshot

BTAI’s price-to-sales ratio: A comparative analysis with its peers

Arcelia Reed

Currently, BioXcel Therapeutics Inc’s (BTAI) stock is trading at $1.97, marking a gain of 6.79% from last night’s close. At ...

Financial Scores

BioXcel Therapeutics Inc (BTAI)’s results reveal risk

Arcelia Reed

While BioXcel Therapeutics Inc has underperformed by -1.96%, investors are advised to look at stock chart patterns for technical insight. ...

Financial Scores

How should investors view BioXcel Therapeutics Inc (BTAI)?

Kenneth Phillips

While BioXcel Therapeutics Inc has underperformed by -1.92%, investors are advised to look at stock chart patterns for technical insight. ...

Financial Scores

BioXcel Therapeutics Inc (BTAI) stock: A year of ups and downs

Preston Campbell

While BioXcel Therapeutics Inc has underperformed by -5.46%, investors are advised to look at stock chart patterns for technical insight. ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.